Here you can read all news about stem cells.

Learn More

Diseases that we treat Media about us MS case studies Stem cells research Statistical report New modern technology

COPD Treatment with Stem Cell Therapy

Chronic obstructive pulmonary disease is one of the most common medical conditions worldwide: research results show that nearly 5% of the population suffers from COPD. It affects men and woman almost equally.

The most frequent causes of obstructive lung disease are asthma, varied conditions of bronchitis, cystic fibrosis, and emphysema that lead to the degeneration or damage to tissue over time.

The main cause of this disease is tobacco smoking: the longer someone smokes, the more likely they are to develop COPD. Nonsmokers can get emphysema (a common type of chronic obstructive lung disease) if they lack the alpha-1 antitrypsin protein, but this case is rare.

Tens of millions of people suffer from lung disease due to smoking, infections or genetic abnormalities. Lung disease can also occur due to malfunction in other systems like congestive heart failure. Risk factors for chronic obstructive pulmonary disease also include the frequent use of cooking gas without proper ventilation, exposure to particular workplace fumes, pollution and secondhand smoke.

COPD symptoms

COPD symptoms include shortness of breath, cough with mucus, recurring respiratory infections, fatigue and wheezing. As the symptoms of COPD develop quite slowly sometimes people are unaware that they have lung problems.

Prognosis: COPD usually gradually gets worse and can lead to death that varies between individuals.

Prognostic factors include:

New Stem Cell Therapy for COPD Patients

There are a number of chemical mechanisms that can influence the typical progressive nature of chronic obstructive pulmonary disease. Without questions the first step is to address the insult and then follow with good respiratory practices. It means potential changes in patient’s lifestyle along with healthy nutritious diet combined with a regime of vitamins and minerals.

Treatment of COPD in Swiss Medica Clinic

When fat-derived stem cells are given intravenously in order to treat these conditions, improvements occur over a period of several weeks: respiratory and forced volume capacity increases, breathing improves, mucous is reduced and scar tissue is reversed. Patents also experience a measurable increase in lung function post treatment.

With our method the highest number of viable stem cells should be used within multiple applications. Procedure includes separating of stem cells from extracted fat, then they are activated and re-delivered directly back into the patient in 2-3 hours time.

Swiss Medica Clinic has developed the Adult Autologous Stem Cell Therapy program to treat a variety of conditions. During stem cell treatment a patient receives 200 – 300 million stem cells. The quantity of restored cells not only covers daily losses, but exceeds them a thousand times. Thus, the reserve of the stem cells, practically lost for the latest 15 – 20 years, is restored. After such an active cell replenishment, organ gets rejuvenated and renewed, because the new and active cells displace the old and damaged ones.

Advantages of Stem Cell Therapy in Swiss Medica clinics:

  1. Side effects and rejection free (use the patient’s very own stem cells from their abdomen)
  2. Avoidance of any allergic and immune reactions (own cells suit chromosomal and genetic structure)
  3. Does not require general anesthesia
  4. No risk of contamination by transmissible diseases
  5. No oncological complications as adult stem cells in comparison to embryonic cells are rather mature
  6. Small quantity of fat tissue is needed (that is why after activation process the stem cells can be at once injected to patient without necessity of growing them on substances. Embryonic stem cells are grown during several months.)
  7. The period of time between getting lipoaspirate and injection of the activated stem cells is only a few hours.
  8. Adipose tissue stem cells are easily accessible and yield up to ten times more stem cells than patient’s bone marrow

Our patients are grateful for the risk-free proven results with the assistance of highly-skilled professionals who understand the importance of personalized care, quality and confidence.

Swiss Medica Clinic is an excellent centre that offers patients the most innovative therapies. We use the unique technology of application of autologous photo activated stem cells previously extracted from fat cells using mini liposuction. The highest standards of treatment and investigative research are upheld at all times.

The package include:

Optional additional therapy:

Cumulative statistical report — COPD cases

The goal of this report is to assess the success of Stem cells treatment in chronic obstructive pulmonary disease patients at Swiss Medica treatment center.

Click on picture to see full report

COPD treatment


What they say about us

All form fields are required.